scispace - formally typeset
Y

Yizhi Liu

Researcher at Sun Yat-sen University

Publications -  348
Citations -  8238

Yizhi Liu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Cataract surgery. The author has an hindex of 37, co-authored 296 publications receiving 5735 citations. Previous affiliations of Yizhi Liu include Peking Union Medical College.

Papers
More filters
Journal ArticleDOI

Refractive error and visual impairment in urban children in southern China

TL;DR: The prevalence of reduced vision because of myopia is high in school-age children living in metropolitan Guangzhou, representing an important public health problem.
Journal ArticleDOI

Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells

TL;DR: The downstream effects of GSH depletion on stress-induced premature senescence (SIPS) and cell death in human RPE cells are examined and it is found that autophagy is activated in the process of ferroptosis and reduces SIPS, suggesting an essential role of autophagic in ferroPTosis and SIPS.
Journal ArticleDOI

An artificial intelligence platform for the multihospital collaborative management of congenital cataracts

TL;DR: It is shown that an AI agent using deep learning, and involving convolutional neural networks for diagnostics, risk stratification and treatment suggestions, accurately diagnoses and provides treatment decisions for congenital cataracts in an in silico test, a website-based study, in a ‘finding a needle in a haystack’ test and in a multihospital clinical trial.
Journal ArticleDOI

WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis

TL;DR: Establishment of an in vitro feeder-cell-free LSC expansion and three-dimensional corneal differentiation protocol in which the transcription factors p63 and PAX6 act together to specify LSCs is found, suggesting a central role of the WNT7A–PAX6 axis in corNEal epithelial cell fate determination, and point to a new strategy for treating corneAL surface diseases.